The DOI matches its Crossref record; 270 of the 270 references it cites were found in a registry or an index.
30 years of dynorphins — New insights on their functions in neuropsychiatric diseases
Open accessAbstract
Since the first description of their opioid properties three decades ago, dynorphins have increasingly been thought to play a regulatory role in numerous functional pathways of the brain. Dynorphins are members of the opioid peptide family and preferentially bind to kappa opioid receptors. In line with their localization in the hippocampus, amygdala, hypothalamus, striatum and spinal cord, their functions are related to learning and memory, emotional control, stress response and pain. Pathophysiological mechanisms that may involve dynorphins/kappa opioid receptors include epilepsy, addiction, depression and schizophrenia. Most of these functions were proposed in the 1980s and 1990s following histochemical, pharmacological and electrophysiological experiments using kappa receptor-specific or general opioid receptor agonists and antagonists in animal models. However, at that time, we had little information on the functional relevance of endogenous dynorphins. This was mainly due to the complexity of the opioid system. Besides actions of peptides from all three classical opioid precursors (proenkephalin, prodynorphin, proopiomelanocortin) on the three classical opioid receptors (delta, mu and kappa), dynorphins were also shown to exert non-opioid effects mainly through direct effects on NMDA receptors. Moreover, discrepancies between the distribution of opioid receptor binding sites and dynorphin immunoreactivity contributed to the difficulties in interpretation. In recent years, the generation of prodynorphin- and opioid receptor-deficient mice has provided the tools to investigate open questions on network effects of endogenous dynorphins. This article examines the physiological, pathophysiological and pharmacological implications of dynorphins in the light of new insights in part obtained from genetically modified animals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–270 of 270
Antidepressant-Like Effect of Endomorphin-1 and Endomorphin-2 in Mice
Fichna, J., Janecka, A. E., Piestrzeniewicz, M. K., Costentin, J., & do-Rego, J.-C. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301149 · Cited by 55
Ma, J., Ye, N., Lange, N., & Cohen, B. M. (2003) · Neuroscience · doi:10.1016/s0306-4522(03)00397-x · Cited by 54
Zhang, L., Peoples, R. W., Öz, M., Harvey-White, J. D., Weight, F. F., & Brauneis, U. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.2.582 · Cited by 54
Distribution of immunoreactive dynorphin B in discrete areas of the rat brain and spinal cord
Zamir, N., Palkovits, M., Weber, E., & Brownstein, M. (1984) · Brain Research · doi:10.1016/0006-8993(84)91346-5 · Cited by 53
Lai, S.-L., Gu, Y., & Huang, L.-Y. M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00293-6 · Cited by 53
Distribution of prodynorphin mRNA and its interaction with the NPY system in the mouse brain
Lin, S., Boey, D., Lee, N. J., Schwarzer, C., Sainsbury, A., & Herzog, H. (2006) · Neuropeptides · doi:10.1016/j.npep.2005.11.006 · Cited by 52
Self-citationNikoshkov, A., Hurd, Y. L., Yakovleva, T., Bazov, I., Marinova, Z., Cebers, G., Pasikova, N. V., Gharibyan, A. L., Terenius, L. Y., & Bakalkin, G. Y. (2005) · The FASEB Journal · doi:10.1096/fj.05-3743fje · Cited by 52
Kappa opioid control of seizures produced by a virus in an animal model
Solbrig, M. V., Adrian, R., Baratta, J. L., Lauterborn, J. C., & Koob, G. F. (2006) · Brain · doi:10.1093/brain/awl008 · Cited by 51
Levels of prodynorphin mRNA in rat dentate gyrus are decreased during hippocampal kindling
MORRIS, B. J., Moneta, M. E., ten Bruggencate, G., & Höllt, V. (1987) · Neuroscience Letters · doi:10.1016/0304-3940(87)90471-x · Cited by 51
Selective kappa antagonist properties of nor-binaltorphimine in the rat mes seizure model
Tortella, F. C., Echevarrı́a, E., Lipkowski, A. W., et al. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90470-0 · Cited by 50
Plnnock, R. D. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90123-j · Cited by 50
Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels
Watkins, L. R., Wiertelak, E. P., & Maier, S. F. (1992) · Brain Research · doi:10.1016/0006-8993(92)90310-6 · Cited by 49
Caudle, R. M., & Dubner, R. A. (1998) · Neuropeptides · doi:10.1016/s0143-4179(98)90022-1 · Cited by 48
Calogero, A. E., Scaccianoce, S., Burrello, N., Nicolai, R., Muscolo, L. A. A., Kling, M. A., Angelucci, L., & D’Agata, R. (1996) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.1996.tb00691.x · Cited by 48
Zamir, N., Palkovits, M., & Brownstein, M. (1984) · Brain Research · doi:10.1016/0006-8993(84)90460-8 · Cited by 48
Seizinger, B. R., Höllt, V., & Herz, A. (1984) · Endocrinology · doi:10.1210/endo-115-2-662 · Cited by 48
Takahashi, M., SENDA, T., Tokuyama, S., & KANETO, H. (1990) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.53.487 · Cited by 48
Reyes, B. A. S., Johnson, A., Glaser, J. D., Commons, K. G., & Bockstaele, E. J. V. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.12.056 · Cited by 47
Motta, V., Penha, K., & Brandão, M. L. (1995) · Psychopharmacology · doi:10.1007/bf02245820 · Cited by 47
Barg, J., Belcheva, M. M., Rowiński, J., & Coscia, C. J. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03314.x · Cited by 47
A comparison of the role of dynorphin in the hippocampal mossy fiber pathway in guinea pig and rat
Salin, P. A., Weisskopf, M. G., & Nicoll, R. A. (1995) · Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06939.1995 · Cited by 46
Lee, P. H. K., Zhao, D., Xie, C. W., McGinty, J. F., Mitchell, C. L., & Hong, J. (1989) · Molecular Brain Research · doi:10.1016/0169-328x(89)90072-7 · Cited by 45
Bockstaele, E. J. V., Gracy, K. N., & Pickel, V. M. (1995) · The Journal of Comparative Neurology · doi:10.1002/cne.903510111 · Cited by 44
Pinnock, R. D. (1992) · Brain Research · doi:10.1016/s0006-8993(10)80029-0 · Cited by 44
Antidepressant-Like Effects of the Novel Kappa Opioid Antagonist MCL-144B in the Forced-Swim Test
Reindl, J. D., Rowan, K. M., Carey, A. N., Peng, X., Neumeyer, J. L., & McLaughlin, J. P. (2008) · Pharmacology · doi:10.1159/000112867 · Cited by 44
Dynorphin A and substance P in the cerebrospinal fluid of schizophrenic patients
Heikkilä, L., Rimón, R., & Ternius, L. (1990) · Psychiatry Research · doi:10.1016/0165-1781(90)90001-l · Cited by 41
Kappa Opioid Receptor Activation Disrupts Prepulse Inhibition of the Acoustic Startle in Rats
Bortolato, M., Aru, G. N., Frau, R., Orrù, M., Fà, M., Manunta, M., Puddu, M., Mereu, G., & Gessa, G. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.02.030 · Cited by 41
Aradi, I., Santhakumar, V., Chen, K., & Soltész, I. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00167-3 · Cited by 41
The distribution of immunoreactive alpha-neo-endorphin in the central nervous system of the rat
Zamir, N., Palkovits, M., & Brownstein, M. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-05-01240.1984 · Cited by 41
Decoy Peptides that Bind Dynorphin Noncovalently Prevent NMDA Receptor-Mediated Neurotoxicity
Woods, A. S., Kaminski, R. M., Öz, M., Wang, Y., Hauser, K. F., Goody, R. J., Wang, H. J., Jackson, S. N., Zeitz, P., Zeitz, K. P., et al. (2006) · Journal of Proteome Research · doi:10.1021/pr060016+ · Cited by 40
Involvement of spinal κ opioid receptors in a type of footshock induced analgesia in mice
Menéndez, L., Andres-Trelles, F., Hidalgo, A., & Baamonde, A. (1993) · Brain Research · doi:10.1016/0006-8993(93)90512-l · Cited by 40
Schepers, R. J., Mahoney, J. L., Gehrke, B. J., & Shippenberg, T. S. (2008) · Pain · doi:10.1016/j.pain.2008.01.023 · Cited by 39
Huge, V., Rammes, G., Beyer, A., Zieglgänsberger, W., & Azad, S. C. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2008.03.010 · Cited by 38
Subcellular targeting of kappa‐opioid receptors in the rat nucleus locus coeruleus
Reyes, B. A. S., Chavkin, C., & Bockstaele, E. J. V. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21880 · Cited by 37
Kappa opioid receptor agonists suppress absence seizures in WAG/Rij rats
Przewłocka, B., Lasoń, W., Machelska, H., van Luijtelaar, G., Coenen, A. M. L., & Przewłocki, R. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11303-e · Cited by 36
Nobre, M. J., Santos, N. R., Aguiar, M. S., & Brandão, M. L. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00589-6 · Cited by 36
Young, E. A., Walker, J. M., Lewis, M. E., Houghten, R. A., Woods, J. H., & Akil, H. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90256-6 · Cited by 35
Lasoń, W., Przewłocka, B., & Przewłocki, R. (1992) · Molecular Brain Research · doi:10.1016/0169-328x(92)90090-x · Cited by 35
Zamir, N., Palkovits, M., & Brownstein, M. (1984) · Journal of Neuroscience · doi:10.1523/jneurosci.04-05-01248.1984 · Cited by 33
Xie, C.-W., Lee, P. H. K., DOUGLASS, J. O., et al. (1989) · Brain Research · doi:10.1016/0006-8993(89)91230-4 · Cited by 32
Prodynorphin Gene Promoter Polymorphism and Temporal Lobe Epilepsy
Gambardella, A., Manna, I., Labate, A., Chifari, R., Serra, P., Russa, A. L., Piane, E. L., Cittadella, R., Andreoli, V., Sasanelli, F., et al. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.18003.x · Cited by 31
Prodynorphin gene expression relates to NF-κB factors
Bakalkin, G. Y., Yakovleva, T., & Terenius, L. Y. (1994) · Molecular Brain Research · doi:10.1016/0169-328x(94)90143-0 · Cited by 31
Horan, P. J., de Costa, B. R., Rice, K. C., Haaseth, R. C., Hruby, V. J., & Porreca, F. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38432-6 · Cited by 31
Marco, E. M., Llorente, R., Pérez-Álvarez, L., Moreno, E., Guaza, C., & Viveros, M. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.05.005 · Cited by 30
Hara, Y., Yakovleva, T., Bakalkin, G. Y., & Pickel, V. M. (2006) · Synapse · doi:10.1002/syn.20273 · Cited by 30
Pierce, J. P., & Milner, T. A. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3<249::aid-syn1006>3.0.co;2-5 · Cited by 29
Allelic Variation in the Human Prodynorphin Gene Promoter and Schizophrenia
Ventriglia, M., Bocchio‐Chiavetto, L., Bonvicini, C., Tura, G. B., Bignotti, S., Racagni, G., & Gennarelli, M. (2002) · Neuropsychobiology · doi:10.1159/000063571 · Cited by 29
Iadarola, M. J., Ofri, D., & Kleinman, J. E. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90224-y · Cited by 27
Rácz, B., & Halasy, K. (2002) · Brain Research · doi:10.1016/s0006-8993(02)02259-x · Cited by 25
The price of seizure control: Dynorphins in interictal and postictal psychosis
Bortolato, M., & Solbrig, M. V. (2007) · Psychiatry Research · doi:10.1016/j.psychres.2006.11.004 · Cited by 24
Campos, D. L., Jiménez‐Díaz, L., Naranjo, J. R., & Carrión, Á. M. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00040-x · Cited by 24
Serotonin: a possible mediator of behavioral suppression induced by anxiety.
Cd, W., Bd, B., & Stein, L. (1970) · PubMed · Cited by 24
Lasoń, W., Przewłocka, B., & Przewłocki, R. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90320-2 · Cited by 22
Halasy, K., Rácz, B., & Maderspach, K. (2000) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(00)00068-5 · Cited by 22
Early Changes in Prodynorphin mRNA and ir‐Dynorphin A Levels after Kindled Seizures in the Rat
Romualdi, P., Donatini, A., Bregola, G., et al. (1995) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1995.tb00705.x · Cited by 22
Human prodynorphin gene generates several tissue-specific transcripts
Telkov, M. V., Geijer, T., & Terenius, L. Y. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00706-9 · Cited by 19
Dynorphin A inhibits NMDA receptors through a pH-dependent mechanism
Kanemitsu, Y., Hosoi, M., Zhu, P., Weight, F. F., Peoples, R. W., McLaughlin, J. S., & Zhang, L. (2003) · Molecular and Cellular Neuroscience · doi:10.1016/s1044-7431(03)00214-8 · Cited by 18
Barr, J. L., & Bockstaele, E. J. V. (2005) · The Anatomical Record Part A Discoveries in Molecular Cellular and Evolutionary Biology · doi:10.1002/ar.a.20184 · Cited by 17
Dynorphin-independent spinal cannabinoid antinociception
Gardell, L. R., Ossipov, M. H., Vanderah, T. W., Lai, J., & Porreca, F. (2002) · Pain · doi:10.1016/s0304-3959(02)00173-2 · Cited by 17
Some projections of dynorphin-immunoreactive neurons in the rat central nervous system
Code, R. A., & Fallon, J. H. (1986) · Neuropeptides · doi:10.1016/0143-4179(86)90043-0 · Cited by 17
Lower CSF level of dynorphin(1–8) immunoreactivity in schizophrenic patients
Zhang, A. Z., Zhou, G. Z., Xi, G.-F., Gu, N. F., Xia, Z. Y., Yao, J., Chang, J. K., Webber, R., & Potkin, S. G. (1985) · Neuropeptides · doi:10.1016/0143-4179(85)90077-0 · Cited by 17
Downstream regulatory element antagonistic modulator regulates islet prodynorphin expression
Jacobson, D. A., Cho, J. Y., Landa, L. R., Tamarina, N. A., Roe, M. W., Buxbaum, J. D., & Philipson, L. H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00612.2005 · Cited by 16
Regional interactions of opioid peptides at μ and δ sites in rat brain
Hewlett, W. A., & Barchas, J. D. (1983) · Peptides · doi:10.1016/0196-9781(83)90080-3 · Cited by 13
Heyliger, S. O., Jackson, C., Rice, K. C., & Rothman, R. B. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19991215)34:4<256::aid-syn2>3.0.co;2-6 · Cited by 13
Seizure-mediated neuronal activation induces DREAM gene expression in the mouse brain
Matsuura, T., Konishi, Y., Aoki, T., Naranjo, J. R., Mikoshiba, K., & Tamura, T. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00562-4 · Cited by 13
Lateralization of dynorphin gene expression in the rat striatum
Capper-Loup, C., & Kaelin‐Lang, A. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.09.071 · Cited by 12
Hypertension and anxiety. A trial with epinephrine and norepinephrine infusion.
Vlachakis, N. D., Guia, D. D., Mendlowitz, M., Antram, S., & Rl, W. (1974) · PubMed · Cited by 12
Millan, M. J., Millan, M. J., Członkowski, A., & Herz, A. (1984) · Brain Research · doi:10.1016/0006-8993(84)91424-0 · Cited by 11
Dynorphin displaces binding at the glycine site of the NMDA receptor in the rat striatum
Voorn, P., Witte, S., Li, K. W., & Jonker, A. J. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.12.041 · Cited by 10
(2000) · doi:10.1002/1520-6394(2000)12:1+<2::aid-da2>3.0.co;2-4
Cited by
Dynorphin, stress, and depression
Knoll, A. T., & Carlezon, W. A. (2010) · Brain Research · doi:10.1016/j.brainres.2009.09.074 · Cited by 465
Singewald, N., Schmuckermair, C., Whittle, N., Holmes, A., & Ressler, K. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.12.004 · Cited by 390
“Another opioid receptor gaining attention in the field of fear extinction is the KOR, activated by endogenous dynorphins (reviewed in Schwarzer, 2009).”
BackgroundThe role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398
Current Research on Opioid Receptor Function
Feng, Y., He, X., Yang, Y., Chao, D., H. Lazarus, L., & Xia, Y. (2012) · Current Drug Targets · doi:10.2174/138945012799201612 · Cited by 329
Role of kappa-opioid receptors in stress and anxiety-related behavior
Van’t Veer, A., & Carlezon, W. A. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3195-5 · Cited by 257
Metadata
- Authors
- Schwarzer, C.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 123
- Issue
- 3
- Pages
- 353-370
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1975064257
- Cited by
- 289
- References
- 270
- FWCI
- 6.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.